Immune to Cancer: The CRI Blog
-
Across the CEO’s Desk: February 2015 Roundup
CRI's CEO Jill O'Donnell-Tormey, PhD, shares some of the latest news in cancer immunotherapy.
-
CRI’s Impact on Colorectal Cancer Immunotherapy
CRI scientists have contributed significantly to the immunological understanding and treatment of colorectal cancer.
-
Five Myths about Clinical Trials that Just Won’t Go Away
Curious about what happens when you enroll in a clinical trial? Hear firsthand about one woman's experience.
-
Alexis and the Young Philanthropists
Since 2008, Alexis Feldman has led a group of highly motivated young New York City professionals who…
-
Knowledge is Love
Spread the word about immunotherapy this Valentine's Day.
-
Immune Checkpoint Inhibitors: What’s Next?
What’s ahead beyond CTLA-4 and PD-1?
-
World Cancer Day: The Many Languages of Cure
From Bengali to Ukrainian, our scientists have one goal: to find a cure for all cancers within…
-
What’s in a Name?
Cancer immunotherapies can have some mind-boggling names. But there’s a reason for it all.
-
Progress Report from the Cancer Immunology “Dream Team”
A group of "star" scientists are investigating new avenues of cancer immunotherapy that will benefit patients.
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.